Cereno Scientific AB (publ)

OTCPK:CRNO.F Stock Report

Market Cap: US$157.4m

Cereno Scientific Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:CRNO.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
08 Jul 26BuyUS$25,681Sten SorensenIndividual48,496US$0.53
07 Jul 26BuyUS$9,431Bjorn DahlofIndividual17,813US$0.53
07 Jul 26BuyUS$25,082Jeppe OvlesenIndividual47,459US$0.53
06 Jul 26BuyUS$25,885Sten SorensenIndividual49,455US$0.52
02 Jul 26BuyUS$10,322Bjorn DahlofIndividual18,165US$0.57
02 Jul 26BuyUS$51,754Sten SorensenIndividual92,592US$0.56

Insider Trading Volume

Insider Buying: CRNO.F insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CRNO.F?
Owner TypeNumber of SharesOwnership Percentage
Private Companies16,541,6895.3%
Individual Insiders23,184,2967.43%
Institutions58,019,81918.6%
General Public214,341,52068.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 20 shareholders own 31.32% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.6%
Avanza Fonder AB
45,598,064US$23.0m0%0.2%
5.3%
Myrlid AS
16,541,689US$8.3m0%no data
1.27%
Andreas Ejlegard
3,965,049US$2.0m0%no data
1.14%
Handelsbanken Asset Management
3,562,349US$1.8m0%no data
1.12%
Jan Butt
3,500,395US$1.8m0%no data
1.06%
Nordnet Pensionsförsäkring AB
3,314,533US$1.7m0%0.18%
1.05%
Fredrik Frank
3,283,556US$1.7m0%no data
0.97%
Dory Gevryie
3,012,235US$1.5m0%no data
0.95%
Swedbank Försäkring AB
2,973,787US$1.5m0%3.35%
0.82%
DNB Asset Management AS
2,571,086US$1.3m0%no data
0.7%
Sten Sorensen
2,185,722US$1.1m9.17%no data
0.61%
Niklas Borgquist
1,893,579US$955.3k0%no data
0.6%
Sverker Jern
1,858,617US$937.7k0%no data
0.51%
Bjorn Dahlof
1,598,974US$806.7k-25.3%no data
0.2%
Anders Svensson
633,144US$319.4k0%no data
0.14%
Nicholas Oakes
433,332US$218.6k0%no data
0.13%
Moi Brajanovic
407,000US$205.3k0%no data
0.088%
Eva Jagenheim
275,000US$138.7k-50%no data
0.043%
Jeppe Ovlesen
132,693US$66.9k55.7%no data
0.0016%
Gunnar Olsson
5,000US$2.5k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/04 20:44
End of Day Share Price 2026/05/07 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cereno Scientific AB (publ) is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jyoti PrakashEdison Investment Research
Oscar Haffen LammStifel, Equities Research